a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
Clinical trial NCT06166836 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06166836
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2027-12-31
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.